Results 231 to 240 of about 6,544,613 (268)

Dark matter matters: from noncoding RNA regulation to cancer immunity. [PDF]

Oncoimmunology
Lteif M, Hijazi A, Morgand E, Van den Eynde M, Salzet M, Galon J.   +5 more
europepmc   +1 more source

Oocyte–cumulus cell interaction: a key factor in early embryo development

Biological Reviews, Volume 101, Issue 5, Page 2265-2278, October 2026.
ABSTRACT The evaluation of oocyte competence is a fundamental step in achieving successful outcomes following assisted reproduction techniques (ART). At present, however, conventional oocyte maturation assessment is carried out by morphological observation, which is a subjective method that does not consider molecular features.
Marc Torres‐Garrido, Marc Yeste, Yentel Mateo‐Otero   +2 more
wiley   +1 more source

LncRNA ckATP1A1-AS1 inhibits influenza A virus replication by mediating innate immune responses and suppressing viral nuclear import. [PDF]

J Virol
Fan M, Liu Z, Deng L, Zheng Y, Zeng Y, Zhang Y, Su J, Xia J, Ping J.   +8 more
europepmc   +1 more source

Immune cells in the pathogenesis of abdominal aortic aneurysm: Roles, regulation and targeted interventions

Clinical and Translational Discovery, Volume 6, Issue 5, October 2026.
This review provides a comprehensive overview of how macrophages, neutrophils, T cells and other immune cells infiltrate the aortic wall, undergo phenotypic shifts and interact with one another in abdominal aortic aneurysm (AAA). Background Abdominal aortic aneurysm (AAA) is a lethal degenerative vascular disease with no approved clinical drugs. Immune
Junqi Peng, Hanqing Zhang, Yun Wu, Song Chen   +3 more
wiley   +1 more source

Long non-coding RNAs in glioblastoma: from molecular drivers to therapeutic targets. [PDF]

Front Immunol
Elemam NM, Sweillam JH, El-Sherif Y, Youssef YA, Ismail HM, Assal RA, Youness RA.   +6 more
europepmc   +1 more source

A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients

International Journal of Cancer, Volume 159, Issue 7, Page 1829-1843, 1 October 2026.
Long non‐coding RNAs (lncRNAs) signatures are promising cancer biomarkers, since their dysregulation in tumors is reflected in body fluids. In this study, next‐generation sequencing, bioinformatics, and gene expression data were combined to investigate an lncRNA signature linked specifically to the cancer‐promoting YAP in several cancer types ...
Fabian Rose, Nada El‐Ekiaby, Lilija Wehling, Sofia Maria Elisabeth Weiler, Jennifer Schmitt, Marcell Tóth, Fabiola Pedrini, Amruta Damle‐Vartak, Carsten Sticht, Rossella Pellegrino, Injie Omar Fawzy, Merna Hatem Mohamed Hamad, Mohamed Negm, Dina Omar, Hossam Eldeen Soliman, Gamal Esmat, Thomas Longerich, Thomas Illig, Bruno Christian Köhler, Anna Saborowski, Heike Bantel, Arndt Vogel, Peter Schirmacher, Ahmed Ihab Abdelaziz, Kai Breuhahn   +24 more
wiley   +1 more source

Noncoding RNA encoded peptides in tumors from discovery to mechanism and clinical translation. [PDF]

iScience
Zhou D, Li H, Yang J, He M, Yang L, Jian L.   +5 more
europepmc   +1 more source

The lncRNA PHAROH augments MYC mRNA levels in insulin-producing cells by counteracting TIA1-induced MYC silencing. [PDF]

Sci Rep
Zhao T, Welsh N.
europepmc   +1 more source

Lung Cancer Chemoresistance: Insights into the Regulatory Role of lncRNAs. [PDF]

Cancer Manag Res
Hou M, Chen J, Yi P, Liu H, Li X, Wang G.   +5 more
europepmc   +1 more source

Mechanistic insights into the lncRNA-Notch signaling axis in tumors. [PDF]

Front Cell Dev Biol
Shi Q, Lou N, Xing H, Fu L.
europepmc   +1 more source